118
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Effect of Different Cryoprotectants on the Survivability and the Development of Bovine Oocytes Matured In vitro

, , &
Pages 15-24 | Received 26 Oct 1999, Accepted 11 May 2000, Published online: 11 Nov 2011
 

Abstract

Tsuzuki. Y., Kusao. T., Ashizawa, K. and Fujihara, N. 2000. Effect of different cryoprotectants on the survivability and the development of bovine oocytes matured in vitro. J. Appl. Anim. Res., 18: 15–24.

To determine the optimum combination of cryoprotectant and freezing method, for improving the developmental, competence of in vitro matured bovine oocytes, three cryoprotectants (1.5 M dimethyl-sulfoxide + 0.25 M sucrose: DMSO; 0.9 M ethylene glycol + 0.8 M propylene glycol + 0.1 M sucrose: EG + PG; 0.8 M PG + 0.8 M DMSO: PG + DMSO) and two freezing methods [the oocytes were cooled from 0C to −6.5C at 1 C/min, seeded and cooled to −30C at 0.3C/min (method A); the oocytes were cooled at −8C directly, seeded and cooled to −35C at 1 C/min (method B)] were used. The survivability and developmental competence of the oocytes thawed from the liquid nitrogen were determined by the dye extrusion assay with eosin and embryonic development after in vitro fertilization, respectively. Without freezing, the survivability of the oocytes equilibrated with and removed from each cryoprotectant were not decreased compared with that in the control group. However, the per cent of the oocyte developed to the blastocyst stage in all of the cryoprotectant treated groups were significantly lower (P<0.05) than that of the control group. DMSO group frozen with method A and EG + PG group frozen with method B maintained their survivability compared to the each control group. However, cleavage rates in all groups were significantly lower (P<0.05)than those of the control groups. No blastocyst was observed in all frozen groups. These results suggest that the combination of DMSO with freezing method A and EG + PG with freezing method B seemed to be more suitable compared with the other combinations.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.